A meta-analysis of antiangiogenic therapy for glioblastoma (GBM).
Mustafa Khasraw
Consultant or Advisory Role - Roche
Research Funding - Merck Serono
Malaka Ameratunga
No relevant relationships to disclose
Andrew B. Lassman
Consultant or Advisory Role - AbbVie; Able Associate; Agenus; Amgen; Defined Health; Easton Associates; Genentech; GlaxoSmithKline; Kyowa Hakko Kirin; Merck Sharp & Dohme; Novartis; RadMD; Roche; Sigma-Tau; Stemline Therapeutics; Synapse; Venture Inflections
Honoraria - Merck Sharp & Dohme; Omniprex
Research Funding - AbbVie; Agenus; Boehringer Ingelheim; Celldex; Genentech; MedImmune; Northwest Biotherapeutics; Novocure; Pfizer
David M. Ashley
No relevant relationships to disclose
Helen Wheeler
Consultant or Advisory Role - Roche
Research Funding - Merck Serono
Nick Pavlakis
No relevant relationships to disclose